New data was published this month in the Journal of the American Academy of Dermatology showing results from an institutional review board-approved survey comparing the propensity for dispensing and dosing calculation errors of HEMANGEOL (propranolol hydrochloride oral solution 4.28 mg/mL) versus generic propranolol hydrochloride oral solutions (4 mg/mL and 8 mg/mL) during the treatment of infantile hemangiomas. The survey of 220 pediatric dermatologists and other physicians who treat infantile hemangioma found that medication dispensing and calculation errors are very common among physicians prescribing generic propranolol vs. HEMANGEOL.
Click here to see our press release.
Patient Education Materials
Download the HEMANGEOL Dosing Chart
You can use this chart as a tool to instruct parents and caregivers on the proper dosing of HEMANGEOL|.
Download the HEMANGEOL Instructions for Use
Parents and caregivers can follow these simple instructions to learn how to properly administer HEMANGEOL.
Download the HEMANGEOL Patient Brochure
This brochure can answer common questions that parents and caregivers may have about infantile hemangioma and HEMANGEOL.
Download the full Prescribing Information for HEMANGEOL
View this document for more information on HEMANGEOL, including indications and usage, dosage and administration, contraindications, as well as warnings and precautions.
Request a Visit If you would like additional information about HEMANGEOL, our dedicated representatives are available to answer your questions and provide you with the resources you need to educate parents and caregivers.
Find Support for Your Patients and Their Loved Ones
There are a number of advocacy groups dedicated to providing education and support to parents and caregivers of infantile hemangioma patients.
Find videos about HEMANGEOL.